Hill's criteria say low vitamin D causes 9 health problems (cancer, CVD, diabetes, MS, dementia, etc.) - review

Vitamin D and Health: Establishing Causal Relationships Through Observational Evidence and Hill’s Criteria in a Biological Framework

Nutrients (MDPI) 2026, 18, 2902, 4 September 2026, https://doi.org/10.3390/nu18172902

William B. Grant, Sunil J. Wimalawansa

Summary by Claude Opus 5 - September, 2026

Bottom line: Two long-time vitamin D researchers argue that, for nine conditions, the accumulated observational evidence satisfies Bradford Hill's classic criteria for causation. They also argue that most vitamin D RCTs were designed in ways that could not detect a benefit.

Type of paper: A peer-reviewed narrative review. It contains no new data and no formal risk-of-bias grading. It mainly revisits earlier published Hill's-criteria analyses and adds newer studies. The nine conditions are cancer, cardiovascular disease, blood pressure, COVID-19, type 1 and type 2 diabetes, periodontal disease, multiple sclerosis, and dementia. Several of the earlier analyses were written by these same authors.

Key points - Why RCTs failed: Large RCTs (VITAL, ViDA, D-Health) enrolled few deficient people and gave a single fixed dose. Placebo groups were often allowed 400–800 IU/day, and results were analyzed by assigned dose rather than achieved 25(OH)D. - Analyzing by achieved level changes the picture: In the D2d prediabetes trial (4,000 IU/day for 2.5 years), people who reached >50 ng/mL had 71% less progression to diabetes (HR 0.29). - Regression dilution: Cohorts that measure vitamin D only once show weaker associations the longer the follow-up runs. - Obesity blunts the benefit: In VITAL, only participants with BMI <25 had a significant (25%) reduction in cancer. - Suggested target: 40–80 ng/mL, ideally at least 50 ng/mL.

The authors conclude that the evidence shows "vitamin D sufficiency reduces risks of several diseases."

What this does NOT show / limitations - Hill's criteria are a judgment framework, not a statistical test. The "experiment" criterion is only weakly met: most RCTs were null, and achieved-level reanalyses are themselves non-randomized. - Mendelian randomization studies are not discussed. - Low vitamin D can be a marker of poor health, obesity, or little time outdoors. Residual confounding and reverse causation are not ruled out. - Study selection was not systematic. The claim that observational studies outrank RCTs for nutrients is a minority position. - The lead author has received research funding from a vitamin D supplement maker (Bio-Tech Pharmacal), which was not involved in this review. - The text contains several citation and typographical errors.

PDF

Clipped from PDF

"Given the absence of evidence of adverse effects within the 40–80 ng/mL range, maintaining serum 25(OH)D concentrations of at least 50 ng/mL may be an effective strategy for optimizing innate immune function ..."

"This narrative review critically evaluates the evidence for cancer, CVD, blood pressure, COVID-19, type 1 and type 2 diabetes, periodontal disease, multiple sclerosis, and dementia. "


Related in VitaminDWiki

Hill's Criteria and vitamin D

Cancer

Cardiovascular

Diabetes

Multiple Sclerosis

Dementia

Hypertension

COVID

Peridontal